Immunomodulator co-therapy is not superior to anti-TNF monotherapy at preventing first loss of response in inflammatory bowel disease patients: long term outcomes in a real world cohort

被引：0

作者：

Varma, P. ^{[1
]}

Rajadurai, A. S. ^{[1
]}

Holt, D. Q. ^{[1
]}

Devonshire, D. A. ^{[1
]}

Desmond, C. P. ^{[1
]}

Swan, M. P. ^{[1
]}

Nathan, D. ^{[1
]}

Shelton, E. T. ^{[1
]}

Prideaux, I. ^{[1
]}

Sorrell, C. ^{[1
]}

Rusli, F. ^{[1
]}

Crantock, L. R. F. ^{[1
]}

Dev, A. T. ^{[1
]}

Ratnam, D. T. ^{[1
]}

Pianko, S. ^{[1
]}

Moore, G. T. ^{[1
]}

机构：

[1] Monash Hlth, Dept Gastroenterol, Clayton, Vic, Australia

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

下载

页码：152 / 152

页数：1

共 50 条

[1] Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease
Mahmoud, Remi
Schultheiss, Hans-Paul
Louwers, Jonas
van der Kaaij, Michiel
van Hellemondt, Boris
Mahmmod, Nofel
van Boeckel, Petra
Jharap, Bindia
Fidder, Herma
Oldenburg, Bas
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (11) : 2577 - +
[2] IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE
Mahmoud, Remi
Schultheiss, Johannes P.
Louwers, Jonas M.
van der Kaaij, Michiel T.
van Hellemondt, Boris P.
Mahmmod, Nofel
van Boeckel, Petra G.
Jharap, Bindia
Fidder, Herma H.
Oldenburg, Bas
GASTROENTEROLOGY, 2022, 162 (07) : S184 - S184
[3] Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort
Varma, Poornima
Rajadurai, Anton S.
Holt, Darcy Q.
Devonshire, David A.
Desmond, Chris P.
Swan, Michael P.
Nathan, Debra
Shelton, Edward T.
Prideaux, Lani
Sorrell, Catherine
Rusli, Ferry
Crantock, Luke R. F.
Dev, Anouk
Ratnam, Dilip T.
Pianko, Stephen
Moore, Gregory T.
INTERNAL MEDICINE JOURNAL, 2019, 49 (06) : 753 - 760
[4] Guide to Discussing the Risks of Immunomodulator and Anti-TNF Therapy with Inflammatory Bowel Disease Patients
Siegel, Corey A.
PRACTICAL GASTROENTEROLOGY, 2007, 31 (11) : 14 - +
[5] EFFECT OF ADDITION OF AN IMMUNOMODULATOR ON OUTCOMES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON ANTI-TNF MONOTHERAPY WITH NEW ANTI-DRUG ANTIBODIES
Portocarrero, Andrea
Chona, Deepika
Hellmann, Jennifer
Minar, Phillip P.
Rosen, Michael J.
GASTROENTEROLOGY, 2019, 156 (06) : S617 - S617
[6] Outcomes post methotrexate salvage therapy after anti-TNF loss of response in inflammatory bowel disease
Cunningham, G.
Kodikara, C.
Varma, P.
Moore, G. T.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 131 - 131
[7] LOSS OF RESPONSE AFTER FIRST LINE ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRATICAL APPROACH AND MANAGEMENT
Guella, S.
Scrivo, B.
Calvaruso, V.
Giuffrida, E.
Busacca, A.
Guida, L.
Carrozza, L.
Cappello, M.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : S136 - S136
[8] Response to Anti-TNF Therapy in Hispanics With Inflammatory Bowel Disease: A Prospective Cohort Study
Bonthala, Nirupama
Demisse, Rahel
Rezapour, Mona
Hwang, Caroline
GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865
[9] ANTI-TNF AND IMMUNOMODULATOR THERAPY MODIFY THE RISK OF ISCHEMIC HEART DISEASE IN PATIENTS WITH SEVERE INFLAMMATORY BOWEL DISEASE
Chen, Chao
Chaudhry, Naueen A.
Hartzema, Abraham
Wang, Wei
Zimmermann, Ellen M.
GASTROENTEROLOGY, 2018, 154 (06) : S374 - S374
[10] Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease
Johannes Stallhofer
Jan Guse
Miriam Kesselmeier
Philip Christian Grunert
Kathleen Lange
Robert Stalmann
Verena Eckardt
Andreas Stallmach
International Journal of Colorectal Disease, 38

← 1 2 3 4 5 →